1.Kelly, R et al. (2016) Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis. Lancet Infectious Diseases 16, 431–440.
5.Heddini, A et al. (2009) Antibiotic resistance in China – a major future challenge. The Lancet 373, 30.
7.National Health and Family Planning Commission of the People's Republic of China (2011) Notice regarding national special measure scheme on clinical use of antibiotics in 2011 [in Chinese]. Available at http://www.nhfpc.gov.cn/zwgkzt/wsbysj/201104/51376.shtml (Accessed October 2018). 9.WHO Collaborating Centre for Drug Statistics Methodology (2014) Guidelines for ATC classification and DDD assignment 2014. Available at http://www.whocc.no/atcddd/ (Accessed 2 April 2014).
10.Clinical and Laboratory Standards Institute (CLSI) (2012) Performance standards for antimicrobial susceptibility testing, 22nd informational supplement. CLSI document M100-S22 (ISBN 1-56238-785-5).
11.Lawes, T et al. (2015) Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated methicillin-resistant Staphylococcus aureus infections across a region of Scotland: a non-linear time-series study. Lancet Infectious Diseases 15, 1438–1449.
12.Vernaz, N et al. (2011) Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community. Journal of Antimicrobial Chemotherapy 66, 928–935.
13.Qu, X et al. (2018) Consumption of antibiotics in Chinese public general tertiary hospitals (2011-2014): trends, pattern changes and regional differences. PLoS ONE 13, e0196668.
16.China Antimicrobial Resistance Surveillance System (2017) A report of China antimicrobial resistance in 2014. Available at http://www.carss.cn/ (Accessed October 2018). 17.China Antimicrobial Resistance Surveillance System (2017) A report of China antimicrobial resistance in 2016. Available at http://www.carss.cn/ (Accessed October 2018).
18.Borg, MA et al. (2010) Antibiotic consumption as a driver for resistance in Staphylococcus aureus and Escherichia coli within a developing region. American Journal of Infection Control 38, 212–216.
19.Tacconelli, E et al. (2008) Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy 61, 26–38.
20.Lai, CC et al. (2011) Correlation between antimicrobial consumption and resistance among Staphylococcus aureus and enterococci causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009. European Journal of Clinical Microbiology and Infectious Diseases 30, 265–271.
21.Salangsang, JA et al. (2010) Patient-associated risk factors for acquisition of methicillin-resistant Staphylococcus aureus in a tertiary care hospital. Infection Control and Hospital Epidemiology 31, 1139–1147.
22.Gladstone, BP et al. (2017) Antimicrobial resistance rates in gram-positive bacteria do not drive glycopeptides use. PLoS ONE 12, e0181358.
23.Mascitti, KB et al. (2012) Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia. Infection Control and Hospital Epidemiology 33, 160–166.
24.Zaoutis, TE et al. (2010) Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clinical Infectious Diseases 51, e38–e45.
25.Ben-Ami, R et al. (2012) Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection. Antimicrobial Agents and Chemotherapy 56, 2518–2523.
26.Banerjee, G and Ray, AK (2016) The talking language in some major Gram-negative bacteria. Archives of Microbiology 198, 489–499.